Overview

Anti-Inflammatory Drug and Endothelial Function

Status:
Unknown status

Trial end date:
2020-06-30

Target enrollment:

Participant gender:

Summary

In this randomized double-blinded clinical trial, 400mg of hydroxychloroquine will be given daily to people over the age of 65 years with moderate-severe obstructive sleep apnea for 8 weeks. The aim of this study is to test whether hydroxychloroquine can improve endothelial function.

Phase:

Phase 4

Details

Lead Sponsor:

Instituto de Cardiologia do Rio Grande do Sul

Collaborator:

Hospital de Clinicas de Porto Alegre

Treatments:

Hydroxychloroquine